| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.12.25 | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 03.12.25 | Why Incannex Is Rising In Pre-market? | 1 | RTTNews | ||
| 03.12.25 | Incannex erhält Fast-Track-Status der FDA für Medikament gegen Schlafapnoe | 4 | Investing.com Deutsch | ||
| 03.12.25 | FDA grants fast track designation to Incannex's OSA treatment | 2 | Investing.com | ||
| 03.12.25 | Incannex Healthcare: Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA) | 221 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies... ► Artikel lesen | |
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 03.12.25 | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.11.25 | Incannex Healthcare Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 30.10.25 | Incannex Healthcare Inc. - 8-K, Current Report | 14 | SEC Filings | ||
| 22.10.25 | Incannex granted extension by Nasdaq to regain compliance with minimum bid price requirement | 1 | Seeking Alpha | ||
| 22.10.25 | Nasdaq gewährt Incannex Healthcare verlängerte Frist zur Erfüllung der Mindestkurs-Anforderung | 1 | Investing.com Deutsch | ||
| 22.10.25 | Incannex Healthcare: Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement | 349 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for... ► Artikel lesen | |
| 22.10.25 | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.09.25 | Incannex Healthcare Inc. - 10-K, Annual Report | 7 | SEC Filings | ||
| 03.09.25 | Interview: IHL-42X showing tangible benefits for patients but market yet to reflect Incannex's pipeline progress, says CEO Joel Latham | 6 | iNVEZZ.com | ||
| 26.08.25 | Incannex meldet positive Phase-2-Studienergebnisse bei Angststörung - Aktie steigt um über 90 % | 4 | Investing.com Deutsch | ||
| 26.08.25 | Incannex reports positive Phase 2 results for anxiety treatment | 1 | Investing.com | ||
| 22.08.25 | Incannex Healthcare Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 22.08.25 | Incannex Healthcare To Repurchase Up To $20 Million In Shares; Stock Up In Pre-market | 1 | RTTNews | ||
| 22.08.25 | Incannex Healthcare shares rise more than 30% on $20M share repurchase program | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| MCKESSON | 694,00 | -1,59 % | McKesson Builds Earnings Momentum on Specialty and Automation | ||
| SENSEONICS | 6,050 | +8,04 % | TD Cowen reiterates Buy rating on Senseonics stock, citing attractive 2026 setup | ||
| PERSPECTIVE THERAPEUTICS | 2,340 | -5,65 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results | Updated interim results from the Company's [212Pb]VMT-a-NET Phase 1/2a study supporting the therapy's compelling overall clinical profile at the 5 mCi dose were presented at the ESMO Congress 2025... ► Artikel lesen | |
| PHETON | 0,470 | +0,62 % | Pheton Holdings Ltd.: Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation | Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen | |
| SRX HEALTH SOLUTIONS | 0,198 | 0,00 % | SRx Health Solutions, Inc.: SRx Health Solutions Regains Compliance with NYSE | NORTH PALM BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that the New York Stock Exchange ("NYSE") has accepted the... ► Artikel lesen | |
| MOVANO | 7,165 | -4,47 % | Corvex To Go Public In All-stock Merger With Movano, Creating A Pure-play Platform For Secure Ai Infrastructure And High-performance Inference | Strategic combination positions combined company to capture AI infrastructure demand at scale
Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GERRESHEIMER | 27,300 | -1,44 % | Gerresheimer AG: Die Klarheit in der Rechnungslegung verbessert sich, aber die Vertrauenslücke bleibt bestehen. HALTEN. | Gerresheimer (GXI) hat das Kapitel der Bill-and-Hold-Buchhaltung abgeschlossen, indem etwa 28 Millionen EUR an Umsätzen für das Geschäftsjahr 2024 vollständig korrigiert wurden, nachdem eine von der... ► Artikel lesen | |
| PROGYNY | 27,440 | 0,00 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO |